Interleukin 35 may contribute to the loss of immunological self‐tolerance in patients with primary immune thrombocytopenia

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|169|2|278-285

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.2, 2015-04, pp. : 278-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Depression in adult patients with primary immune thrombocytopenia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E462-E463

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : E40-E43

John Wiley & Sons Inc

Access to resources Recommend Favorite

United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findings

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 590-594

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of rituximab and dexamethasone on regulatory and proinflammatory B‐cell subsets in patients with primary immune thrombocytopenia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 45-52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population‐based study in France

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : 301-305

John Wiley & Sons Inc

Access to resources Recommend Favorite